Synthesis, single crystal XRD, in-vitro, and in-silico studies of polysubstituted tetrahydropyridine as α-amylase inhibitor

The inhibition of alpha-amylase, an enzyme responsible for the breakdown of starch, has gained opulent attention as a therapeutic target for managing conditions such as diabetes and obesity. In that spirit, the synthesis of densely substituted tetrahydropyridines (PMAAA - PMAAH) as a potential alpha-amylase inhibitor was herein undertaken. The obtained compounds were thoroughly characterized utilizing C-13-NMR, H-1-NMR, and FT-IR spectroscopic techniques, confirming their structural integrity and purity. Single crystal XRD analysis was also performed to determine the crystal structure of the PMAAA, providing valuable insights into its molecular arrangement and intermolecular interactions. Furthermore, in-silico studies were employed to gain a deeper understanding of the binding interactions between the PMAAA and the active site of alpha-amylase. The supramolecular assembly was mainly stabilized by H-bonding and explored by Hirshfeld surface analysis. Void analysis predicted the mechanical response of the crystal. alpha-Amylase inhibition study has shown that PMAAA demonstrated an IC50 value of 40.54 +/- 5.0 mg/mL, compared to 8.80 +/- 0.21 mg/mL for acarbose as a reference inhibitor. To further explore the interaction of PMAAA with alpha-amylase, a molecular docking simulation was performed. The docking analysis showed that there is a strong interaction between the PMAAA ligand and alpha-amylase, with a binding score of -8.4 kcal/mol. These findings pave the way for further research and potential applications in the management of conditions related to alpha-amylase dysregulation, such as diabetes and obesity.